NRI Pulse
Business

Ranbaxy to pay $40 mn to settle Texas litigation

New Delhi, Oct 16 (IANS) Drugmaker Ranbaxy Laboratories Thursday said it has settled the litigation concerning its participation in the Texas Medicaid Program and agreed to pay $39.75 million.

The company has informed this to the Bombay Stock Exchange (BSE) in a filing.

It said: “Ranbaxy has settled the litigation concerning its participation in the Texas Medicaid Program. Under the settlement agreement, Ranbaxy will make payments to the State of Texas totalling $39.75 million in a series of tranches through August 2015.”

The company is in the process of being acquired by larger rival Sun Pharmaceutical Industries Ltd.

Ranbaxy shares traded at Rs.589.85 per share, down 1.37 percent, at the BSE during the closing at 4 p.m. Thursday.

Related posts

Batch of Maggi ordered off-shelf, Nestle says safety norms strict

Veena

US interested to become partner country in Vibrant Gujarat

Veena

Amazon to start online ‘queues’ for new customers as demand surges

Veena

Leave a Comment